Browse drugs

…dentified Capillaria philippinensis and Opisthorchis viverrini. Albendazole and praziquantel produced rapid diarrhea resolution; albumin re…

… with re-emergence of haemolysis during initial steroid course. Rituximab offered a turning point, demonstrating the utility of targeted …

…fractory SSc with the plasma cell-depleting bispecific antibody teclistamab ( table 1). After six cycles of teclistamab, 1g of rituximab wa…

… mean disease duration was 7.2±6.2 years. All patients received prednisolone at mean dose of 10.6±4.3 mg/day. 9% of patients received cyclop…

…of the disease and lung damage. Thus, a decrease in ET-1 during rituximab therapy, may indicate a positive response to therapy.…

…nts recieved corticosteroids, and 48.7% recieved antimalarials. Mycophenolate mofetil, rituximab and cyclophosphamide were the most commonly used imm…

…received glucocorticoids(GC) and immunosuppressants(IS),45(68%)-rituximab(RTM) at cumulative dose 2.4±1.5 grams.The level of TGF-B,ET-1,V…

… (SSc) patients. The recent ERS/EULAR guidelines recommend both mycophenolate mofetil (MMF) and rituximab (RTX) for SSc-ILD and suggest to use a comb…

…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…

…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…

…through CMR. Based on recent evidence, combination therapy with rituximab (RTX, 2 x 1000 mg with a two-week gap and a repeat dose after s…

…SP was 21mmHg. HRCT Scan confirmed mild ILD.He was commenced on mycophenolate mofetil, amlodipine and omeprazole. Mid-2023 he presented with shortnes…